K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Impact of imaging measurements on response assessment in glioblastoma clinical trials
TL;DR: Historical and scientific guidance on imaging response assessment for incorporation into clinical trials to stimulate effective and expedited drug development for recurrent glioblastoma is provided.
Journal ArticleDOI
Pragmatic study designs for older adults with cancer: Report from the U13 conference.
Ryan D. Nipp,Nengliang Aaron Yao,Lisa M. Lowenstein,Jan C. Buckner,Ira R. Parker,Ajeet Gajra,Ajeet Gajra,Vicki A. Morrison,William Dale,Karla V. Ballman +9 more
TL;DR: By strategically utilizing pragmatic clinical trials to test therapies and interventions that have previously shown efficacy in younger, fitter patients, these trials represent a potential mechanism to improve the evidence base in geriatric oncology and enhance care for older adults with cancer.
Journal ArticleDOI
Challenges Faced by Medical Journals During the COVID-19 Pandemic.
Journal ArticleDOI
Alveolar Macrophage Immunometabolism and Lung Function Impairment in Smoking and Chronic Obstructive Pulmonary Disease.
Sarah L. O’Beirne,Sarah Ann Kikkers,Clara Oromendia,Jacqueline Salit,Mahboubeh R. Rostmai,Karla V. Ballman,Robert J. Kaner,Ronald G. Crystal,Suzanne M. Cloonan +8 more
TL;DR: In this paper, the number of alveolar macrophages (AMs), the most abundant antigen-presenting cells in the lung, is increased in the lungs of individuals with chronic obstructive pulmonary disease (COPD), associating with disease severity and areas of lung destruction.
Journal ArticleDOI
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort
William Z. Zhang,William Z. Zhang,Michelle C. Rice,Katherine Hoffman,Clara Oromendia,Igor Barjaktarevic,J. Michael Wells,Annette T. Hastie,Wassim W. Labaki,Christopher B. Cooper,Alejandro P. Comellas,Gerard J. Criner,Jerry A. Krishnan,Robert Paine,Nadia N. Hansel,Russell P. Bowler,R. Graham Barr,Stephen P. Peters,Prescott G. Woodruff,Jeffrey L. Curtis,Jeffrey L. Curtis,MeiLan K. Han,Karla V. Ballman,Fernando J. Martinez,Fernando J. Martinez,Augustine M.K. Choi,Kiichi Nakahira,Suzanne M. Cloonan,Mary E. Choi,Mary E. Choi +29 more
TL;DR: U-mtDNA levels may help to identify distinct clinical phenotypes and underlying pathobiological differences in males versus females with COPD.